[HTML][HTML] Adjunct N-acetylcysteine treatment in hospitalized patients with HIV-associated tuberculosis dampens the oxidative stress in peripheral blood: Results from …

…, AMS Andrade, R Spener-Gomes… - Frontiers in …, 2021 - frontiersin.org
Tuberculosis (TB) still causes significant morbidity and mortality worldwide, especially in
persons living with human immunodeficiency virus (HIV). This disease is hallmarked by …

The Xpert MTB/RIF Cycle Threshold Value Predicts Mycobacterium tuberculosis Transmission to Close Contacts in a Brazilian Prospective Multicenter Cohort

…, M Araújo-Pereira, R Spener-Gomes… - Clinical Infectious …, 2024 - academic.oup.com
Background The Xpert MTB/RIF rapid molecular test provides a quantitative measure of
Mycobacterium tuberculosis (Mtb) DNA in the form of cycle threshold (Ct) values. This …

The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study

…, MS Rocha, AB Souza, R Spener-Gomes… - The Journal of …, 2022 - academic.oup.com
Background It is unclear whether diabetes or prediabetes affects unfavorable treatment
outcomes and death in people with tuberculosis (PWTB). Methods Culture-confirmed, drug-…

[HTML][HTML] Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study …

IP Safe, MVG Lacerda, VS Printes, AF Praia Marins… - PLoS …, 2020 - journals.plos.org
Despite the availability of effective antimicrobials, tuberculosis (TB) is still a serious health
threat. Mortality is even higher in people living with HIV who are diagnosed with TB. New …

Lessons learned from implementation of an interferon gamma release assay to screen for latent tuberculosis infection in a large multicenter observational cohort study …

…, HNS Ibiapina, R Spener-Gomes… - Microbiology …, 2021 - Am Soc Microbiol
The interferon gamma release assay (IGRA) has emerged as a useful tool for identifying latent
tuberculosis infection (LTBI). This assay can be performed through testing platforms such …

[HTML][HTML] Immunologic biomarkers in peripheral blood of persons with tuberculosis and advanced HIV

…, JP Miguez-Pinto, R Spener-Gomes… - Frontiers in …, 2022 - frontiersin.org
Introduction Tuberculosis (TB) is a common opportunistic infection among people living with
HIV. Diagnostic tests such as culture, Xpert-MTB-RIF, and ULTRA have low sensitivity in …

Isoniazid monoresistance and antituberculosis treatment outcome in persons with pulmonary tuberculosis in Brazil

…, ACC Carvalho, R Spener-Gomes… - Open Forum …, 2024 - academic.oup.com
Background The high burden of drug-resistant tuberculosis (TB) is a problem to achieve the
goals of the End TB Strategy by 2035. Whether isoniazid monoresistance (Hr) affects anti-TB …

[HTML][HTML] Feasibility of GeneXpert® edge for tuberculosis diagnosis in difficult-to-reach populations: preliminary results of a proof-of-concept study

…, J dos Santos Pinheiro, R Spener-Gomes… - The American Journal …, 2020 - ncbi.nlm.nih.gov
GeneXpert® Edge (GX-Edge) is a new point-of-care platform not yet tested in the field. In
this proof-of-concept study conducted for the diagnosis of tuberculosis in communities living …

[HTML][HTML] Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study

…, BMF Nogueira, R Spener-Gomes… - Journal of infection and …, 2023 - Elsevier
Background Tuberculosis (TB) remains a major plague of humanity. People with TB (PWTB)
are commonly anemic. Here, we assessed whether the severity of anemia in PWTB prior to …

[HTML][HTML] Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil

…, MMS Rodrigues, R Spener-Gomes… - Frontiers in …, 2022 - frontiersin.org
Background There are scarce data on the prevalence and disease presentation of HIV in
patients with tuberculosis (TB) and dysglycemia (diabetes [DM] and prediabetes [PDM]), …